Dune Medical Devices has obtained approval in Europe to market a next-generation version of its MarginProbe System console, a device used for intra-operative tissue evaluation during early-stage breast cancer procedures. The MarginProbe System Type 1.2 improves on the original model with a more compact size, better aesthetics and enhanced overall design.

Full Story:
Boston Herald

Related Summaries